HsBCL9CT-24
HsBCL9CT-24 is a Wnt/β-catenin (b-cat) pathway inhibitor with potent anti-tumor effect. hsBCL9CT-24 reactivates anti-cancer immune response suppressed by the oncogenic Wnt pathway and can be utilized for cancer research[1].
Product Specifications
CAS Number
2094604-98-3
UNSPSC
12352209
Target
Wnt; β-catenin
Type
Peptides
Related Pathways
Stem Cell/Wnt
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hsbcl9ct-24.html
Smiles
O=C([C@@H](NC(C)=O)CC(C)C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@](CCCC=C)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@](CCCC=C)(C(N[C@H](C(N)=O)CC(C)C)=O)C)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)[C@H](CC)C)=O)C)=O)CCCNC(N)=N)=O)CC(C)C)=O)[C@@H](C)O)=O)CCC(N)=O
Molecular Formula
C68H122N20O15
Molecular Weight
1459.82
References & Citations
[1]Feng M, et al. Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells. Sci Adv. 2019 May 8;5 (5) :eaau5240.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog